Find Flutamide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

110 RELATED EXCIPIENT COMPANIES

185EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 13311-84-7, Eulexin, Niftolide, Niftholide, Sch 13521, 2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
Molecular Formula
C11H11F3N2O3
Molecular Weight
276.21  g/mol
InChI Key
MKXKFYHWDHIYRV-UHFFFAOYSA-N
FDA UNII
76W6J0943E

Flutamide
An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Flutamide is an Androgen Receptor Inhibitor. The mechanism of action of flutamide is as an Androgen Receptor Antagonist.
1 2D Structure

Flutamide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
2.1.2 InChI
InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)
2.1.3 InChI Key
MKXKFYHWDHIYRV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
76W6J0943E
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Apimid

2. Apo Flutamide

3. Apo-flutamide

4. Apoflutamide

5. Chimax

6. Cytamid

7. Drogenil

8. Euflex

9. Eulexin

10. Eulexine

11. Fluken

12. Flulem

13. Flumid

14. Fluta 1a Pharma

15. Fluta Cell

16. Fluta Gry

17. Fluta-cell

18. Fluta-gry

19. Flutacell

20. Flutagry

21. Flutamin

22. Flutandrona

23. Flutaplex

24. Flutexin

25. Fugerel

26. Grisetin

27. Niftolid

28. Niftolide

29. Novo Flutamide

30. Novo-flutamide

31. Novoflutamide

32. Oncosal

33. Pms Flutamide

34. Pms-flutamide

35. Prostacur

36. Prostica

37. Prostogenat

38. Sch 13521

39. Sch-13521

40. Sch13521

41. Testotard

2.3.2 Depositor-Supplied Synonyms

1. 13311-84-7

2. Eulexin

3. Niftolide

4. Niftholide

5. Sch 13521

6. 2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

7. Nfba

8. Niftolid

9. Drogenil

10. Flutamin

11. Cebatrol, Veterinary

12. Flutamida

13. Flutamidum

14. Sch-13521

15. 4'-nitro-3'-trifluoromethylisobutyranilide

16. 2-methyl-n-(4-nitro-3-[trifluoromethyl]phenyl)propanamide

17. N-(4-nitro-3-(trifluoromethyl)phenyl)isobutyramide

18. Sch13521

19. Mfcd00072009

20. Nsc 215876

21. Flutamide (eulexin)

22. Alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide

23. Chembl806

24. Propanamide, 2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)-

25. Propanamide, 2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]-

26. Nsc-215876

27. 4-nitro-3-(trifluoromethyl)isobutyranilide

28. Chebi:5132

29. 76w6j0943e

30. Ncgc00015452-09

31. Eulexine

32. Chimax

33. 4'-nitro-3'-trifluoromethylisobutyramilide

34. Cas-13311-84-7

35. Ham's F-12 Medium

36. Flutamidum [inn-latin]

37. Dsstox_cid_11121

38. Dsstox_rid_78899

39. Dsstox_gsid_32004

40. Flutamida [inn-spanish]

41. Flutamide Usp25

42. N-[4-nitro-3-(trifluoromethyl)phenyl]isobutyramide

43. Prostandril

44. Odyne

45. .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-m-propionotoluidide

46. Smr000058187

47. Eulexin (tn)

48. Ccris 7246

49. M-propionotoluidide,.alpha.,.alpha.-trifluoro-

50. Sr-01000075888

51. 4'-nitro-3'-(trifluoromethyl)isobutyranilide

52. Einecs 236-341-9

53. Brn 2157663

54. .alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-m-propionotoluidide

55. M-propionotoluidide,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-

56. Unii-76w6j0943e

57. Flutamide [usan:usp:inn:ban]

58. Flutamide,(s)

59. Prestwick_228

60. Nk-601

61. Spectrum_001210

62. 2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propionamide

63. Cpd000058187

64. Flutamide [inn]

65. Flutamide [jan]

66. Flutamide [mi]

67. Flutamide [usan]

68. Prestwick0_000180

69. Prestwick1_000180

70. Prestwick2_000180

71. Prestwick3_000180

72. Spectrum2_001201

73. Spectrum3_001421

74. Spectrum4_000829

75. Spectrum5_001450

76. Lopac-f-9397

77. F0663

78. Flutamide (pubertal Study)

79. Flutamide [mart.]

80. F 9397

81. Flutamide [usp-rs]

82. Flutamide [who-dd]

83. Schembl3934

84. Lopac0_000557

85. Bspbio_000079

86. Bspbio_003122

87. Kbiogr_001377

88. Kbioss_001690

89. Mls000069634

90. Mls001065596

91. Mls002548892

92. Divk1c_000459

93. Spectrum1500995

94. Spbio_000982

95. Spbio_002000

96. Flutamide (jp17/usp/inn)

97. Bpbio1_000087

98. Gtpl6943

99. Flutamide [ep Impurity]

100. Flutamide [orange Book]

101. Chembl4759307

102. Dtxsid7032004

103. Flutamide [ep Monograph]

104. Schembl12932289

105. Hms501g21

106. Kbio1_000459

107. Kbio2_001690

108. Kbio2_004258

109. Kbio2_006826

110. Kbio3_002342

111. Flutamide [usp Monograph]

112. Ninds_000459

113. Hms1568d21

114. Hms1921o16

115. Hms2090i18

116. Hms2092o14

117. Hms2095d21

118. Hms2230p19

119. Hms3259i03

120. Hms3261p15

121. Hms3373c12

122. Hms3655g22

123. Hms3712d21

124. Pharmakon1600-01500995

125. Amy32524

126. Bcp23006

127. Hy-b0022

128. Zinc3812944

129. Tox21_110154

130. Tox21_202169

131. Tox21_300536

132. Tox21_500557

133. Bdbm50131270

134. Ccg-39105

135. M-propionotoluidide, 2-methyl-4'-nitro-alpha,alpha,alpha-triflouro-

136. M-propionotoluidide, Alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-

137. Nsc147834

138. Nsc215876

139. Nsc757817

140. S1908

141. Akos001025465

142. Akos025243203

143. M-propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-

144. Tox21_110154_1

145. Ab02835

146. Db00499

147. Ks-5091

148. Lp00557

149. Nc00451

150. Nsc-147834

151. Nsc-757817

152. Sdccgsbi-0050540.p004

153. Idi1_000459

154. Ncgc00015452-01

155. Ncgc00015452-02

156. Ncgc00015452-03

157. Ncgc00015452-04

158. Ncgc00015452-05

159. Ncgc00015452-06

160. Ncgc00015452-07

161. Ncgc00015452-08

162. Ncgc00015452-10

163. Ncgc00015452-11

164. Ncgc00015452-12

165. Ncgc00015452-13

166. Ncgc00015452-14

167. Ncgc00015452-15

168. Ncgc00015452-16

169. Ncgc00015452-19

170. Ncgc00015452-20

171. Ncgc00015452-32

172. Ncgc00091460-01

173. Ncgc00091460-02

174. Ncgc00091460-03

175. Ncgc00091460-04

176. Ncgc00091460-05

177. Ncgc00091460-06

178. Ncgc00091460-07

179. Ncgc00091460-08

180. Ncgc00091460-09

181. Ncgc00254495-01

182. Ncgc00259718-01

183. Ncgc00261242-01

184. Ac-24192

185. Bf166239

186. Sy036411

187. Sbi-0050540.p003

188. Db-042163

189. 3'-trifluoromethyl-4'-nitro-isobutyranilide

190. Ab00052188

191. Eu-0100557

192. Ft-0626493

193. Ft-0668764

194. Sw196536-4

195. 4''-nitro-3''-trifluoromethylisobutyranilide

196. C07653

197. D00586

198. Ab00052188-09

199. Ab00052188_10

200. Ab00052188_11

201. 311f847

202. A806562

203. Q418669

204. Q-201131

205. Sr-01000075888-1

206. Sr-01000075888-6

207. Sr-01000075888-7

208. Sr-01000075888-9

209. Brd-k28307902-001-05-0

210. Flutamide, Certified Reference Material, Tracecert(r)

211. Z56755651

212. A,a,a-trifluoro-2-methyl-4'-nitro- M-propionotoluidide

213. Flutamide, European Pharmacopoeia (ep) Reference Standard

214. 2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide #

215. Flutamide, United States Pharmacopeia (usp) Reference Standard

216. 2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide;flutamide

217. Alpha,alpha,alpha-trifluoro-2-methyl-4''-nitro-m-propionotoluidide

218. M-propionotoluidide, 2-methyl-4'-nitro-.alpha.,.alpha.,.alpha.-trifluoro-

219. Flutamide For System Suitability, European Pharmacopoeia (ep) Reference Standard

220. 37209-54-4

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 276.21 g/mol
Molecular Formula C11H11F3N2O3
XLogP33.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count2
Exact Mass276.07217670 g/mol
Monoisotopic Mass276.07217670 g/mol
Topological Polar Surface Area74.9 Ų
Heavy Atom Count19
Formal Charge0
Complexity352
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameFlutamide
PubMed HealthFlutamide (By mouth)
Drug ClassesAntiandrogen
Drug LabelFlutamide capsules contain flutamide, an acetanilid, nonsteroidal, orally active antiandrogen having the chemical name, ,,-trifluoro-2-methyl-4'-nitrom-propionotoluidide.Each capsule contains 125 mg flutamide. The compound is a buff to yellow p...
Active IngredientFlutamide
Dosage FormCapsule
RouteOral
Strength125mg
Market StatusPrescription
CompanyActavis Labs Fl; Par Pharm; Ivax Sub Teva Pharms; Mylan

2 of 2  
Drug NameFlutamide
PubMed HealthFlutamide (By mouth)
Drug ClassesAntiandrogen
Drug LabelFlutamide capsules contain flutamide, an acetanilid, nonsteroidal, orally active antiandrogen having the chemical name, ,,-trifluoro-2-methyl-4'-nitrom-propionotoluidide.Each capsule contains 125 mg flutamide. The compound is a buff to yellow p...
Active IngredientFlutamide
Dosage FormCapsule
RouteOral
Strength125mg
Market StatusPrescription
CompanyActavis Labs Fl; Par Pharm; Ivax Sub Teva Pharms; Mylan

4.2 Drug Indication

For the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Flutamide is a nonsteroidal antiandrogen. In animal studies, flutamide demonstrates potent antiandrogenic effects. It exerts its antiandrogenic action by inhibiting androgen uptake and/or by inhibiting nuclear binding of androgen in target tissues or both. Prostatic carcinoma is known to be androgen-sensitive and responds to treatment that counteracts the effect of androgen and/or removes the source of androgen, e.g. castration. Elevations of plasma testosterone and estradiol levels have been noted following flutamide administration.


5.2 MeSH Pharmacological Classification

Antineoplastic Agents, Hormonal

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)


Androgen Antagonists

Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
FLUTAMIDE
5.3.2 FDA UNII
76W6J0943E
5.3.3 Pharmacological Classes
Androgen Receptor Inhibitor [EPC]; Androgen Receptor Antagonists [MoA]
5.4 ATC Code

L02BB01

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


L - Antineoplastic and immunomodulating agents

L02 - Endocrine therapy

L02B - Hormone antagonists and related agents

L02BB - Anti-androgens

L02BB01 - Flutamide


5.5 Absorption, Distribution and Excretion

Absorption

Rapidly and completely absorbed.


Route of Elimination

Flutamide and its metabolites are excreted mainly in the urine with only 4.2% of a single dose excreted in the feces over 72 hours.


5.6 Metabolism/Metabolites

Flutamide is rapidly and extensively metabolized, with flutamide comprising only 2.5% of plasma radioactivity 1 hour after administration.


Flutamide has known human metabolites that include 2-hydroxy-flutamide.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.7 Biological Half-Life

The plasma half-life for the alpha-hydroxylated metabolite of flutamide (an active metabolite) is approximately 6 hours.


5.8 Mechanism of Action

Flutamide is a nonsteroidal antiandrogen that blocks the action of both endogenous and exogenous testosterone by binding to the androgen receptor. In addition Flutamide is a potent inhibitor of testosterone-stimulated prostatic DNA synthesis. Moreover, it is capable of inhibiting prostatic nuclear uptake of androgen.


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Empty Capsules

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Coloring Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Odyne Manufacturers

A Odyne manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Odyne, including repackagers and relabelers. The FDA regulates Odyne manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Odyne API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Odyne manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Odyne Suppliers

A Odyne supplier is an individual or a company that provides Odyne active pharmaceutical ingredient (API) or Odyne finished formulations upon request. The Odyne suppliers may include Odyne API manufacturers, exporters, distributors and traders.

click here to find a list of Odyne suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Odyne USDMF

A Odyne DMF (Drug Master File) is a document detailing the whole manufacturing process of Odyne active pharmaceutical ingredient (API) in detail. Different forms of Odyne DMFs exist exist since differing nations have different regulations, such as Odyne USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Odyne DMF submitted to regulatory agencies in the US is known as a USDMF. Odyne USDMF includes data on Odyne's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Odyne USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Odyne suppliers with USDMF on PharmaCompass.

Odyne JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Odyne Drug Master File in Japan (Odyne JDMF) empowers Odyne API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Odyne JDMF during the approval evaluation for pharmaceutical products. At the time of Odyne JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Odyne suppliers with JDMF on PharmaCompass.

Odyne CEP

A Odyne CEP of the European Pharmacopoeia monograph is often referred to as a Odyne Certificate of Suitability (COS). The purpose of a Odyne CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Odyne EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Odyne to their clients by showing that a Odyne CEP has been issued for it. The manufacturer submits a Odyne CEP (COS) as part of the market authorization procedure, and it takes on the role of a Odyne CEP holder for the record. Additionally, the data presented in the Odyne CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Odyne DMF.

A Odyne CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Odyne CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Odyne suppliers with CEP (COS) on PharmaCompass.

Odyne WC

A Odyne written confirmation (Odyne WC) is an official document issued by a regulatory agency to a Odyne manufacturer, verifying that the manufacturing facility of a Odyne active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Odyne APIs or Odyne finished pharmaceutical products to another nation, regulatory agencies frequently require a Odyne WC (written confirmation) as part of the regulatory process.

click here to find a list of Odyne suppliers with Written Confirmation (WC) on PharmaCompass.

Odyne NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Odyne as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Odyne API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Odyne as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Odyne and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Odyne NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Odyne suppliers with NDC on PharmaCompass.

Odyne GMP

Odyne Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Odyne GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Odyne GMP manufacturer or Odyne GMP API supplier for your needs.

Odyne CoA

A Odyne CoA (Certificate of Analysis) is a formal document that attests to Odyne's compliance with Odyne specifications and serves as a tool for batch-level quality control.

Odyne CoA mostly includes findings from lab analyses of a specific batch. For each Odyne CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Odyne may be tested according to a variety of international standards, such as European Pharmacopoeia (Odyne EP), Odyne JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Odyne USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty